These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

411 related items for PubMed ID: 19426981

  • 21. Association between angiographic complications and clinical outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention: an EARLY ACS (Early Glycoprotein IIb/IIIa Inhibition in Non-ST-Segment Elevation Acute Coronary Syndrome) angiographic substudy.
    Pride YB, Mohanavelu S, Zorkun C, Kunadian V, Giugliano RP, Newby LK, Braunwald E, Califf RM, Harrington RA, Gibson CM, EARLY ACS Investigators.
    JACC Cardiovasc Interv; 2012 Sep; 5(9):927-35. PubMed ID: 22995880
    [Abstract] [Full Text] [Related]

  • 22. Association of impaired thrombolysis in myocardial infarction myocardial perfusion grade with ventricular tachycardia and ventricular fibrillation following fibrinolytic therapy for ST-segment elevation myocardial infarction.
    Gibson CM, Pride YB, Buros JL, Lord E, Shui A, Murphy SA, Pinto DS, Zimetbaum PJ, Sabatine MS, Cannon CP, Josephson ME, TIMI Study Group.
    J Am Coll Cardiol; 2008 Feb 05; 51(5):546-51. PubMed ID: 18237683
    [Abstract] [Full Text] [Related]

  • 23. Comparison of myocardial reperfusion in patients undergoing percutaneous coronary intervention in ST-segment elevation acute myocardial infarction with versus without diabetes mellitus (from the EMERALD Trial).
    Marso SP, Miller T, Rutherford BD, Gibbons RJ, Qureshi M, Kalynych A, Turco M, Schultheiss HP, Mehran R, Krucoff MW, Lansky AJ, Stone GW.
    Am J Cardiol; 2007 Jul 15; 100(2):206-10. PubMed ID: 17631071
    [Abstract] [Full Text] [Related]

  • 24. Early abciximab administration before primary percutaneous coronary intervention improves clinical outcome in diabetic patients with ST-segment elevation myocardial infarction (EUROTRANSFER Registry).
    Dziewierz A, Mielecki W, Siudak Z, Rakowski T, Janzon M, Birkemeyer R, Zasada W, Dubiel JS, Dudek D.
    Atherosclerosis; 2012 Jul 15; 223(1):212-8. PubMed ID: 22658254
    [Abstract] [Full Text] [Related]

  • 25. Net clinical benefit of prehospital glycoprotein IIb/IIIa inhibitors in patients with ST-elevation myocardial infarction and high risk of bleeding: effect of tirofiban in patients at high risk of bleeding using CRUSADE bleeding score.
    Hermanides RS, Ottervanger JP, ten Berg JM, Gosselink AT, van Houwelingen G, Dambrink JH, Stella PR, Hamm C, van 't Hof AW, On-TIME 2 Trial Investigators.
    J Invasive Cardiol; 2012 Mar 15; 24(3):84-9. PubMed ID: 22388296
    [Abstract] [Full Text] [Related]

  • 26. Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction.
    Henriques JP, Zijlstra F, Ottervanger JP, de Boer MJ, van 't Hof AW, Hoorntje JC, Suryapranata H.
    Eur Heart J; 2002 Jul 15; 23(14):1112-7. PubMed ID: 12090749
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS)--study design.
    Svilaas T, van der Horst IC, Zijlstra F.
    Am Heart J; 2006 Mar 15; 151(3):597.e1-597.e7. PubMed ID: 16504620
    [Abstract] [Full Text] [Related]

  • 29. Effects of baseline coronary occlusion and diabetes mellitus in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Piccolo R, Galasso G, Iversen AZ, Eitel I, Dominguez-Rodriguez A, Gu YL, de Smet BJ, Mahmoud KD, Abreu-Gonzalez P, Trimarco B, Thiele H, Piscione F.
    Am J Cardiol; 2014 Oct 15; 114(8):1145-50. PubMed ID: 25193670
    [Abstract] [Full Text] [Related]

  • 30. Comparison of prognostic value of epicardial blood flow and early ST-segment resolution after primary coronary angioplasty. ANIN--Myocardial Infarction Registry.
    Kalińczuk Ł, Przyłuski J, Karcz M, Petryka J, Kaczmarska E, Bekta P, Kepka C, Kruk M, Pregowski J, Kadziela J, Deptuch T, Skwarek M, Cedro K, Ciszewski M, Debski A, Ciszewski A, Chmielak Z, Demkow M, Witkowski A, Ruzyłło W.
    Kardiol Pol; 2007 Jan 15; 65(1):1-10; discussion 11-2. PubMed ID: 17295155
    [Abstract] [Full Text] [Related]

  • 31. Value of platelet reactivity in predicting response to treatment and clinical outcome in patients undergoing primary coronary intervention: insights into the STRATEGY Study.
    Campo G, Valgimigli M, Gemmati D, Percoco G, Tognazzo S, Cicchitelli G, Catozzi L, Malagutti P, Anselmi M, Vassanelli C, Scapoli G, Ferrari R.
    J Am Coll Cardiol; 2006 Dec 05; 48(11):2178-85. PubMed ID: 17161242
    [Abstract] [Full Text] [Related]

  • 32. Benefits from intracoronary as compared to intravenous abciximab administration for STEMI patients undergoing primary angioplasty: a meta-analysis of 8 randomized trials.
    De Luca G, Verdoia M, Suryapranata H.
    Atherosclerosis; 2012 Jun 05; 222(2):426-33. PubMed ID: 22483166
    [Abstract] [Full Text] [Related]

  • 33. Comparative early and late outcomes after primary percutaneous coronary intervention in ST-segment elevation and non-ST-segment elevation acute myocardial infarction (from the CADILLAC trial).
    Cox DA, Stone GW, Grines CL, Stuckey T, Zimetbaum PJ, Tcheng JE, Turco M, Garcia E, Guagliumi G, Iwaoka RS, Mehran R, O'Neill WW, Lansky AJ, Griffin JJ, CADILLAC Investigators.
    Am J Cardiol; 2006 Aug 01; 98(3):331-7. PubMed ID: 16860018
    [Abstract] [Full Text] [Related]

  • 34. Impact of vessel size on distal embolization, myocardial perfusion and clinical outcome in patients undergoing primary angioplasty for ST-segment elevation myocardial infarction.
    De Luca G, Suryapranata H, de Boer MJ, Ottervanger JP, Hoorntje JC, Gosselink AT, Dambrink JH, van't Hof AW.
    J Thromb Thrombolysis; 2009 Feb 01; 27(2):198-203. PubMed ID: 18097637
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. The effect of pre-hospital glycoprotein IIb-IIIa inhibitors on angiographic outcome in STEMI patients who are candidates for primary PCI.
    Hermanides RS, van Werkum JW, Ottervanger JP, Breet NJ, Gosselink AT, van Houwelingen KG, Dambrink JH, Hamm C, ten Berg JM, van 't Hof AW, Ongoing Tirofiban In Myocardial infarction Evaluation (On-TIME) 2 study group.
    Catheter Cardiovasc Interv; 2012 May 01; 79(6):956-64. PubMed ID: 22162050
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.